logo
episode-header-image
Sep 2021
44m 6s

Understanding Evergrande, Dell’s Post-Sp...

CNBC
About this episode
Carl Quintanilla, Jim Cramer and David Faber discuss China’s property market crisis and the Federal Reserve's decision to keep current monetary stimulus in place for just a little bit longer. The Food and Drug Administration has authorized Pfizer and BioNTech’s Covid-19 booster shots for people 65 and older and other vulnerable Americans six months after the ... Show More
Up next
Yesterday
11AM Hour: AI Safety Concerns in Focus, Oil Prices on the Rise & Apple and OpenAI Head to Court 9/14/26
We break down the latest in the AI space as Anthropic CEO Dario Amodei and OpenAI CEO Sam Altman call for a slowdown in development. Then, Former Product Executive at Google and Meta Rob Leathern joins with his reaction to the growing concerns around AI safety. Rapidan Energy CEO ... Show More
42m 44s
Yesterday
10AM Hour: AI Leaders Call for Slowdown, President’s Trump’s Response, CEO of the AI Chip Firm Challenging Nvidia 9/14/26
Tech leaders are sounding the alarm over the pace of AI development. Early Anthropic investor Byron Deeter joins Squawk on the Street to discuss the calls to slow down—and what that could mean for AI spending and the IPO pipeline. That’s as President Trump takes to social media, ... Show More
44m 8s
Yesterday
9AM HOUR: AI Leaders Call For Slowdown, Chips Slide, OpenAI's Altman Rules Out 2026 IPO 9/14/26
Carl Quintanilla, David Faber and Sara Eisen covered lots of AI news moving the markets: Chip stocks tumbled after AI industry leaders called for an AI slowdown. Anthropic CEO Dario Amodei set the tone with his essay on the topic. OpenAI CEO Sam Altman and SpaceX and Tesla CEO El ... Show More
42m 25s
Recommended Episodes
Apr 2022
COVID Outbreaks, Semiconductor GARP Stocks & Off The Charts 4/13/22
The Dow climbed over 300 points after two days of losses, and Jim Cramer is taking investors through the market's gains after yesterday's dip. Next, with the pandemic still weighing on the stock market, Cramer’s checking in with Dr. Eric Topol on the current state of COVID. Then, ... Show More
44m 41s
Feb 2023
CNBC Special Report: Taking Stock 2/14/23
<p>CNBC’s Frank Holland has your post-CPI playbook. Bleakley Advisory Group’s Peter Boockvar discusses the hotter-than-expected CPI report and what it means for the Fed going forward. David Steinberg, co-founder and CEO of Zeta Global, a data-driven cloud marketing company, discu ... Show More
44m 51s
Nov 2023
Stocks Jump After Fed Pause, and Is Now the Time to Buy China? 11/1/23
<p>Major indexes all closed higher after the central bank, as expected, held rates steady for a second straight meeting. We dig in on chair Powell’s commentary and what it means for the markets. Plus, Yum Brands, Estee Lauder and Canada Goose among the companies raising concerns ... Show More
44m 44s
Nov 2020
A Vaccine Boost
Pfizer announces encouraging results from its COVID-19 vaccine. Disney gives investors 73 million reasons for optimism. Beyond Meat reports a surprising loss. Lyft reports a surprising increase in revenue. And DoorDash prepares for an IPO. Motley Fool analysts Ron Gross and Jason ... Show More
39m 10s
Oct 2024
US stocks get tech boost
<p>Global markets saw divergent trends, with European stocks struggling due to a falling oil price and high China exposure, while US markets saw a broad-based rally driven by positive tech sector news. Bond yields steadied, and investors await the release of the FOMC minutes for ... Show More
16m 2s
Feb 2020
Record Highs, Coronavirus Concerns, Facebook’s New Hobby
Nvidia shakes off its “crypto hangover” and reports blowout earnings. Shopify soars. Pepsi surprises. And Roku rises. Motley Fool analysts Emily Flippen, Ron Gross, and Jason Moser discuss those stories and weigh in on the latest from Mattel, Lyft, Under Armour, and Restaurant Br ... Show More
41m 41s
Aug 2021
U.S. To Urge Covid-19 Booster Shots
Michael Dowling, CEO at Northwell Health, discusses the U.S. government expected to recommend booster shots eight months after people get their second vaccine dose. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Deals Reporter Scott Deveau talk about how the SPAC boo ... Show More
35m 26s
May 2021
Pfizer’s Results, What’s Next for Retail & Restaurants, The High Bar for CRISPR & More
<p>It has been a busy few days for the United States as the pandemic-related news has been fast and furious. Pfizer reported better-than-expected profits and a lot of its revenue has come from the COVID-19 vaccine. Maxx Chatsko joins Dan Kline to talk about that, President Joe Bi ... Show More
58m 18s
Feb 2024
Tech headaches weigh on broader market
<p>Concerns that Nvidia may miss high expectations for its quarterly results and that the technology sector is overvalued have weighed on the broader US equity market. Later today, investors will look to the January FOMC meeting minutes for fresh clues on the Federal Reserve’s ou ... Show More
15m 21s
Aug 2021
U.S. To Offer Covid-19 Boosters in September
Dr. William Haseltine, Chair and President of Access Health International, discusses the Biden administration offering Covid boosters starting in late September. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Finance Reporter Sri Natarajan talk about Wall Street brin ... Show More
36m 5s